Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Levitzki

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Cytokine & Growth Factor Reviews|June 23, 2004
PDGF receptor kinase inhibitors for the treatment of PDGF driven diseasesAlexander Levitzki
Nature Biotechnology|September 2, 2003
The closure of SugenAlexander Levitzki
Accounts of Chemical Research|June 18, 2003
Protein kinase inhibitors as a therapeutic modalityAlexander Levitzki
Annual Review of Pharmacology and Toxicology|October 10, 2012
Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performanceAlexander Levitzki
Frontiers in Oncology|June 1, 2012
Targeting the Immune System to Fight Cancer Using Chemical Receptor Homing Vectors Carrying Polyinosine/Cytosine (PolyIC)Alexander Levitzki
European Journal of Cancer (Oxford, England : 1990)|January 17, 2003
Tyrosine kinases as targets for cancer therapyAlexander Levitzki
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
EGF receptor as a therapeutic targetAlexander Levitzki
Cardiovascular Research|January 25, 2005
PDGF receptor kinase inhibitors for the treatment of restenosisAlexander Levitzki
Chembiochem : a European Journal of Chemical Biology|September 5, 2002
G-protein subunit dissociation is not an integral part of G-protein actionAlexander Levitzki, Shoshana Klein
Annual Review of Biochemistry|June 8, 2006
Tyrphostins and other tyrosine kinase inhibitorsAlexander Levitzki, Eyal Mishani
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Cytokine & Growth Factor Reviews|June 23, 2004
PDGF receptor kinase inhibitors for the treatment of PDGF driven diseasesAlexander Levitzki
Nature Biotechnology|September 2, 2003
The closure of SugenAlexander Levitzki
Accounts of Chemical Research|June 18, 2003
Protein kinase inhibitors as a therapeutic modalityAlexander Levitzki
Annual Review of Pharmacology and Toxicology|October 10, 2012
Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performanceAlexander Levitzki
Frontiers in Oncology|June 1, 2012
Targeting the Immune System to Fight Cancer Using Chemical Receptor Homing Vectors Carrying Polyinosine/Cytosine (PolyIC)Alexander Levitzki
European Journal of Cancer (Oxford, England : 1990)|January 17, 2003
Tyrosine kinases as targets for cancer therapyAlexander Levitzki
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
EGF receptor as a therapeutic targetAlexander Levitzki
Cardiovascular Research|January 25, 2005
PDGF receptor kinase inhibitors for the treatment of restenosisAlexander Levitzki
Chembiochem : a European Journal of Chemical Biology|September 5, 2002
G-protein subunit dissociation is not an integral part of G-protein actionAlexander Levitzki, Shoshana Klein
Annual Review of Biochemistry|June 8, 2006
Tyrphostins and other tyrosine kinase inhibitorsAlexander Levitzki, Eyal Mishani
Pageof 10